Journal
JOURNAL OF OBSTETRICS AND GYNAECOLOGY
Volume 29, Issue 4, Pages 288-295Publisher
TAYLOR & FRANCIS INC
DOI: 10.1080/01443610902812709
Keywords
Methylmalonic acid; Nigeria; pregnant women; subclinical vitamin B12 deficiency
Categories
Ask authors/readers for more resources
Inadequate vitamin B12 status in a pregnant woman increases the risk for adverse maternal and fetal outcomes. The use of serum vitamin B 12 concentration alone to assess vitamin B 12 status in pregnant women is unreliable because of the decrease in serum vitamin B 12 levels in normal pregnancy. The combination of serum vitamin B 12 and methylmalonic acid (MMA) concentrations may provide a better estimate of vitamin B12 status. We obtained blood samples from 98 pregnant women in the third trimester at an antenatal clinic in Jos, Nigeria. All subjects were taking iron and folate supplements. Twelve of the subjects had a serum vitamin B 12 concentration <148 pmol/l and 18 subjects had a serum MMA level >271 nmol/l. Using a combination of low serum vitamin B12 and elevated MMA concentrations, eight subjects were classified as having subclinical vitamin B 12 deficiency. Because of the potential harmful consequences of vitamin B 12 deficiency in pregnant women, it would be advisable to add vitamin B12 supplements to the existing regimen of folate and iron supplements currently provided to pregnant women in Nigeria.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available